
SBRA Stock Forecast & Price Target
SBRA Analyst Ratings
Bulls say
Sabra Health Care REIT Inc has demonstrated an improvement in its financial metrics, with the net debt to adjusted EBITDA ratio decreasing to 5.3x from 5.7x over the past year, reflecting enhanced operational efficiency. The company has also reported a 4Q24 Core FFO of $0.35 per share, aligning with consensus expectations, and subsequently raised its Core FFO estimates for FY2025 and FY2026, indicating positive momentum in earnings. Additionally, Sabra's strong liquidity position of $953.9 million and robust performance in its skilled nursing and SHOP assets positions the company favorably for growth in a competitive industry.
Bears say
Sabra Health Care REIT faces substantial financial challenges due to a heightened debt level, which may hinder its ability to meet financial obligations and sustain business operations. The reliance on government reimbursements and the potential for loss of licenses pose significant risks to revenue generation, especially considering potential regulatory compliance issues and reimbursement rate reductions. Furthermore, difficulties in accessing external capital for future investments may limit growth opportunities and delay recovery on investments, while competitive pressures exacerbate operational uncertainties.
This aggregate rating is based on analysts' research of Sabra Health Care and is not a guaranteed prediction by Public.com or investment advice.
SBRA Analyst Forecast & Price Prediction
Start investing in SBRA
Order type
Buy in
Order amount
Est. shares
0 shares